Numab Therapeutics raises $55 million to advance its multi-specific antibody pipeline targeting inflammation and oncology, ...

USA-based Climb Bio said yesterday it has entered into an exclusive license agreement with Beijing Mabworks Biotech for ...

UCB partners with Ailux Biologics to use XtalPi's AI-driven XtalFold platform for antibody discovery and optimization. The ...

Spanish firm Grifols has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US ...

German pharma major Bayer today announced top-line results of the Phase III study OASIS 4 investigating elinzanetant as ...

MitoRx Therapeutics strengthens its leadership with the appointments of Lubor Gaal as chief business officer and Stacey ...

Sanofi reports positive Phase III results for a subcutaneous version of Sarclisa in relapsed or refractory multiple myeloma.

German family-owned pharma major Boehringer Ingelheim has licensed antibody-drug conjugates ADC technology from ...

UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from ...

Intelligence provider Clarivate has released the 12th annual Drugs to Watch report, a guide to the therapies poised to ...

Swiss oncology-focused Araris Biotech developing next-generation antibody drug conjugates (ADCs), today announced a research ...

Shares in French food allergy biotech DBV Technologies (Nasdaq: DBVT) looked set to close more than 10% higher on Thursday.